Flow Chemistry Market Is Witnessing Rampant Growth As Uniqsis Ltd Receives Two Major Orders Of Its Flow Chemistry System Flowsyn From South African Pharmaceutical Industry


Flow Chemistry refers to the physical manipulation of an organic compound with flow lines, pumps, or any other means to improve the concentration or vaporization of a compound's product, liquid, or solution. The application of this method depends on various factors such as the type of compound to be analyzed, its physical state at the time of analysis, and the properties of the analyzer itself. In many cases, it is necessary to combine several different techniques in order to get an accurate measurement. A wide variety of biological processes is also carried out by flow chemistry including protein synthesis, transcription, differentiation, growth, maintenance, and other biological functions. Many enzymes are activated by flow reactions and are used in a wide range of biochemistry processes.

Increasing demand from the chemicals industry is expected to drive growth of the global flow chemistry market during the forecast period. Flow chemistry is typically used in the chemicals industry where starting materials are in limited supply and small reactions are preferable. These include potentially hazardous reactions such as oxidations, halogenations, nitration, hydrogenation, diazotizations, and reactions that use toxic gases. Flow chemistry offers numerous advantages such as faster & safer reactions, cleaner products, rapid reaction optimization, easy scale-up, and integrated synthesis. In chemicals industry, flow chemistry is mainly used by fertilizer and sugar manufacturers for high-volume products and low prices. During bulk production, flow chemistry offers convenience and makes the entire procedure economic. The chemical industry in both developed and emerging economies has witnessed significant growth over the years. According to the India Brand Equity Foundation (IBEF), the chemical sector in India is expected to reach US$ 300 billion by 2025. Hence, these factors are expected to drive growth of the global flow chemistry market growth over the forecast period. Moreover, rapid growth of the pharmaceutical industry is expected to boost the global flow chemistry market growth over the forecast period.

High cost associated with R&D combined with a stringent regulatory framework by authorities is expected to hinder the global flow chemistry market growth over the forecast period. Besides, manufacturing of bulk chemicals can present lucrative growth opportunities in the global flow chemistry market in the near future. Among regions, North America is expected to witness significant growth in the global flow chemistry market during the forecast period. This is owing to the presence of large number of chemical manufacturers and technological advancements in the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing demand for generic drugs in the region.

Key companies involved in the global flow chemistry market are Am Technology, PDC Machines Inc., CEM Corporation, Future Chemistry Holding BV, Milestone Srl, Ehrfeld Mikrotechnik BTS, Syrris Ltd., Uniqsis Ltd., Cambridge Reactor Design Ltd., Parr Instrument Company, Future Chemistry Holding BV, and ThalesNano Inc.

For instance, in May 2019, Uniqsis Ltd received two major orders for its FlowSyn, flow chemistry systems from South African Pharmaceutical Industry

Location: India

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more